{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:44:22Z","timestamp":1788410662111,"version":"build-2803163510"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T00:00:00Z","timestamp":1520899200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s10096-018-3222-x","type":"journal-article","created":{"date-parts":[[2018,3,13]],"date-time":"2018-03-13T12:34:57Z","timestamp":1520944497000},"page":"1099-1102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":49,"title":["Susceptibility profile of echinocandins, azoles and amphotericin B against yeast phase of Talaromyces marneffei isolated from HIV-infected patients in Guangdong, China"],"prefix":"10.1007","volume":"37","author":[{"given":"H.-L.","family":"Lei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.-H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-N.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.-Y.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.-P.","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.-P.","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,13]]},"reference":[{"issue":"1","key":"3222_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1128\/CMR.19.1.95-110.2006","volume":"19","author":"N Vanittanakom","year":"2006","unstructured":"Vanittanakom N, Cooper CR Jr, Fisher MC, Sirisanthana T (2006) Penicillium marneffei infection and recent advances in the epidemiology and molecular biology aspects. Clin Microbiol Rev 19(1):95\u2013110. \n                    https:\/\/doi.org\/10.1128\/CMR.19.1.95-110.2006","journal-title":"Clin Microbiol Rev"},{"key":"3222_CR2","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1038\/emi.2016.18","volume":"5","author":"JF Chan","year":"2016","unstructured":"Chan JF, Lau SK, Yuen KY, Woo PC (2016) Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients. Emerg Microbes Infect 5:e19. \n                    https:\/\/doi.org\/10.1038\/emi.2016.18","journal-title":"Emerg Microbes Infect"},{"key":"3222_CR3","doi-asserted-by":"publisher","unstructured":"Peng J, Chen Z, Cai R, Huang X, Lin L, Liang W, Xiong Z, Chen J, Chen H, Yang Y, Liu S, Jiang Q (2017) Recovery from Talaromyces marneffei involving the kidney in a renal transplant recipient: a case report and literature review. Transpl Infect Dis 19(4). \n                    https:\/\/doi.org\/10.1111\/tid.12710","DOI":"10.1111\/tid.12710"},{"issue":"3","key":"3222_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s11046-010-9363-9","volume":"171","author":"DQ Luo","year":"2011","unstructured":"Luo DQ, Chen MC, Liu JH, Li Z, Li HT (2011) Disseminated Penicillium marneffei infection in an SLE patient: a case report and literature review. Mycopathologia 171(3):191\u2013196. \n                    https:\/\/doi.org\/10.1007\/s11046-010-9363-9","journal-title":"Mycopathologia"},{"issue":"7","key":"3222_CR5","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1093\/cid\/cir028","volume":"52","author":"T Le","year":"2011","unstructured":"Le T, Wolbers M, Chi NH, Quang VM, Chinh NT, Lan NP, Lam PS, Kozal MJ, Shikuma CM, Day JN, Farrar J (2011) Epidemiology, seasonality, and predictors of outcome of AIDS-associated Penicillium marneffei infection in Ho Chi Minh City, Viet Nam. Clin Infect Dis 52(7):945\u2013952. \n                    https:\/\/doi.org\/10.1093\/cid\/cir028","journal-title":"Clin Infect Dis"},{"issue":"1","key":"3222_CR6","first-page":"89","volume":"30","author":"S Nong","year":"2013","unstructured":"Nong S, Liang J (2013) Bone marrow Penicillium marneffei infection in acquired immunodeficiency syndrome patients: report of 35 cases. Trop Biomed 30(1):89\u201391","journal-title":"Trop Biomed"},{"issue":"2","key":"3222_CR7","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3201\/eid1702.100718","volume":"17","author":"C Cao","year":"2011","unstructured":"Cao C, Liang L, Wang W, Luo H, Huang S, Liu D, Xu J, Henk DA, Fisher MC (2011) Common reservoirs for Penicillium marneffei infection in humans and rodents, China. Emerg Infect Dis 17(2):209\u2013214. \n                    https:\/\/doi.org\/10.3201\/eid1702.100718","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"3222_CR8","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"H Masur","year":"2014","unstructured":"Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE, National Institutes of H, Centers for Disease C, Prevention, America HIVMAotIDSo (2014) Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: updated guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 58(9):1308\u20131311. \n                    https:\/\/doi.org\/10.1093\/cid\/ciu094","journal-title":"Clin Infect Dis"},{"issue":"5\u20136","key":"3222_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11046-016-0107-3","volume":"182","author":"Y Ouyang","year":"2017","unstructured":"Ouyang Y, Cai S, Liang H, Cao C (2017) Administration of voriconazole in disseminated Talaromyces (Penicillium) marneffei infection: a retrospective study. Mycopathologia 182(5\u20136):569\u2013575. \n                    https:\/\/doi.org\/10.1007\/s11046-016-0107-3","journal-title":"Mycopathologia"},{"issue":"9","key":"3222_CR10","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.4103\/0366-6999.180520","volume":"129","author":"HR Li","year":"2016","unstructured":"Li HR, Cai SX, Chen YS, Yu ME, Xu NL, Xie BS, Lin M, Hu XL (2016) Comparison of Talaromyces marneffei infection in human immunodeficiency virus-positive and human immunodeficiency virus-negative patients from Fujian, China. Chin Med J 129(9):1059\u20131065. \n                    https:\/\/doi.org\/10.4103\/0366-6999.180520","journal-title":"Chin Med J"},{"issue":"4","key":"3222_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/civ1194","volume":"62","author":"PG Pappas","year":"2016","unstructured":"Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, Reboli AC, Schuster MG, Vazquez JA, Walsh TJ, Zaoutis TE, Sobel JD (2016) Clinical practice guideline for the Management of Candidiasis: 2016 update by the Infectious Diseases Society of America. Clin Infect Dis 62(4):e1\u201350. \n                    https:\/\/doi.org\/10.1093\/cid\/civ933","journal-title":"Clin Infect Dis"},{"issue":"5","key":"3222_CR12","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1055\/s-0035-1562902","volume":"36","author":"NM Clark","year":"2015","unstructured":"Clark NM, Grim SA, Lynch JP 3rd (2015) Posaconazole: use in the prophylaxis and treatment of fungal infections. Semin Respir Crit Care Med 36(5):767\u2013785. \n                    https:\/\/doi.org\/10.1055\/s-0035-1562902","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"3222_CR13","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1128\/JCM.40.5.1739-1742.2002","volume":"40","author":"N Vanittanakom","year":"2002","unstructured":"Vanittanakom N, Vanittanakom P, Hay RJ (2002) Rapid identification of Penicillium marneffei by PCR-based detection of specific sequences on the rRNA gene. J Clin Microbiol 40(5):1739\u20131742. \n                    https:\/\/doi.org\/10.1128\/JCM.40.5.1739-1742.2002","journal-title":"J Clin Microbiol"},{"key":"3222_CR14","doi-asserted-by":"publisher","unstructured":"Chaiwarith R, Supparatpinyo K (2016) Talaromyces (Penicillium) marneffei and HIV.1\u20139. \n                    https:\/\/doi.org\/10.1007\/978-1-4614-9610-6_419-1","DOI":"10.1007\/978-1-4614-9610-6_419-1"},{"issue":"4","key":"3222_CR15","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s10156-012-0511-7","volume":"19","author":"D Liu","year":"2013","unstructured":"Liu D, Liang L, Chen J (2013) In vitro antifungal drug susceptibilities of Penicillium marneffei from China. J Infect Chemother 19(4):776\u2013778. \n                    https:\/\/doi.org\/10.1007\/s10156-012-0511-7","journal-title":"J Infect Chemother"},{"key":"3222_CR16","doi-asserted-by":"publisher","unstructured":"Lau SKP, Lo GCS Lam CS, Chow WN, Ngan AH, Wu AK, Tsang DN, Tse CW, Que TL, Tang BS, Woo PC (2017) In vitro activity of posaconazole against Talaromyces marneffei by broth microdilution and Etest methods and comparison to itraconazole, voriconazole, and anidulafungin. Antimicrob Agents Chemother 61 (3). \n                    https:\/\/doi.org\/10.1128\/AAC.01480-16","DOI":"10.1128\/AAC.01480-16"},{"issue":"3","key":"3222_CR17","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1128\/JCM.01840-06","volume":"45","author":"BD Alexander","year":"2007","unstructured":"Alexander BD, Byrne TC, Smith KL, Hanson KE, Anstrom KJ, Perfect JR, Reller LB (2007) Comparative evaluation of Etest and sensititre yeastone panels against the clinical and laboratory standards institute M27-A2 reference broth microdilution method for testing Candida susceptibility to seven antifungal agents. J Clin Microbiol 45(3):698\u2013706. \n                    https:\/\/doi.org\/10.1128\/JCM.01840-06","journal-title":"J Clin Microbiol"},{"key":"3222_CR18","first-page":"1","volume":"32","author":"Clinical and Laboratory Standards Institute","year":"2013","unstructured":"Clinical and Laboratory Standards Institute (2013) Reference method for broth dilution antifungal susceptibility testing of yeasts. Fourth Informat Suppl 32:1\u201323","journal-title":"Fourth Informat Suppl"},{"issue":"4","key":"3222_CR19","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1128\/AAC.47.4.1376-1381.2003","volume":"47","author":"T Nakai","year":"2003","unstructured":"Nakai T, Uno J, Ikeda F, Tawara S, Nishimura K, Miyaji M (2003) In vitro antifungal activity of micafungin (FK463) against dimorphic fungi: comparison of yeast-like and mycelial forms. Antimicrob Agents Chemother 47(4):1376\u20131381. \n                    https:\/\/doi.org\/10.1128\/aac.47.4.1376-1381.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"3222_CR20","doi-asserted-by":"publisher","first-page":"1912","DOI":"10.1128\/AAC.48.5.1912-1915.2004","volume":"48","author":"O Zekaver","year":"2004","unstructured":"Zekaver O, Paetznick VL, Rodriguez JR, Enuo C, Ostrosky-Zeichner L (2004) In vitro activity of anidulafungin against selected clinically important mold isolates. Antimicrob Agents Chemother 48(5):1912\u20131915. \n                    https:\/\/doi.org\/10.1128\/AAC.48.5.1912-1915.2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"3222_CR21","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1080\/21505594.2016.1193275","volume":"7","author":"A Sapmak","year":"2016","unstructured":"Sapmak A, Kaewmalakul J, Nosanchuk JD, Vanittanakom N, Andrianopoulos A, Pruksaphon K, Youngchim S (2016) Talaromyces marneffei laccase modifies THP-1 macrophage responses. Virulence 7(6):702\u2013717. \n                    https:\/\/doi.org\/10.1080\/21505594.2016.1193275","journal-title":"Virulence"},{"issue":"1","key":"3222_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.bjid.2012.06.027","volume":"17","author":"D Goncalves","year":"2013","unstructured":"Goncalves D, Ferraz C, Vaz L (2013) Posaconazole as rescue therapy in African histoplasmosis. Braz J Infect Dis 17(1):102\u2013105. \n                    https:\/\/doi.org\/10.1016\/j.bjid.2012.06.027","journal-title":"Braz J Infect Dis"},{"issue":"12","key":"3222_CR23","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/cid\/cir734","volume":"53","author":"R Schein","year":"2011","unstructured":"Schein R, Homans J, Larsen RA, Neely M (2011) Posaconazole for chronic refractory coccidioidal meningitis. Clin Infect Dis 53(12):1252\u20131254. \n                    https:\/\/doi.org\/10.1093\/cid\/cir734","journal-title":"Clin Infect Dis"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-018-3222-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3222-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-018-3222-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,3,12]],"date-time":"2019-03-12T20:36:07Z","timestamp":1552422967000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-018-3222-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,13]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3222"],"URL":"https:\/\/doi.org\/10.1007\/s10096-018-3222-x","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,13]]},"assertion":[{"value":"12 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the institutional review board of Guangzhou Eighth People\u2019s Hospital, which contained only sub-cultured clinical\n                      T. marneffei\n                      isolates and all patient information were anonymised. Informed consent was not required in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement and informed consent"}}]}}